AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland
The progressive neurological disorder affects approximately 12,400 people in Scotland
Read More
Tag: AbbVie
AbbVie’s Skyrizi shows promise as personalised treatment for psoriasis
The immunosuppressant reduced inflammation in patients with the skin condition after three days
Read More
Marketing authorisation for AbbVie’s Aquipta
The therapy has been developed for the treatment of migraine among adults
Read More
NICE recommendation for AbbVie’s Rinvoq
The approved drug has been developed to treat patients with moderate to severe Crohn’s disease
Read More
AbbVie reveals results from pivotal atogepant trial
Study has been focusing on atogepant for the prevention of episodic migraine attacks
Read More
Green light for AbbVie’s Crohn’s disease therapy Rinvoq
MHRA approval for Rinvoq which treats adults with moderate to severely active Crohn’s Disease
Read More
AbbVie and Eli Lilly snub drug pricing agreement
Major industry names depart leaving UK pricing deal in serious jeopardy
Read More
NICE recommendation expands patient eligibility for AbbVie’s Ozurdex
Treatment becomes an option for treating visual impairment caused by diabetic macular oedema, regardless of lens status
Read More
AbbVie’s Rinvoq gains recommended approval by CHMP
CHMP returns positive opinion on Rinvoq for the treatment of adults with active non-radiographic axial spondyloarthritis
Read More
AbbVie and Cerebras Systems partner to accelerate AI research
Link up between AbbVie and Cerebras Systems boosts AI platforms, while radically reducing energy consumption
Read More
AbbVie and We Are Pioneer Group link to accelerate life-changing innovations
Golden Ticket programme is open to early-stage life sciences companies and biotech start-ups which are focusing on cutting edge therapies
Read More
NICE backs Rinvoq for moderate active RA
Decision expands access to oral therapy to around 27,000 people in England
Read More
- US study reveals interferon combinations cause lupus symptoms and affect treatment
- NIHR and TJBCM announce new funding initiative for novel brain tumour research
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
